60K views · 1.8K reactions | HONORING A VACCINE SCIENTIST: "The View" praises a scientist who’s an expert on the front lines of the global race for a SARS-CoV-2 vaccine, Dr. Kizzmekia Corbett. Learn how she’s making history developing the science that could end the pandemic. abcn.ws/3j56ZWu | The View | Facebook

12K views · 256 reactions | The mRNA-1273 SARS-CoV-2 vaccine had high short-term efficacy, but its medium-term efficacy and safety are not known. https://nej.md/2YfXzla | The New England Journal of Medicine | Facebook

21K views · 618 reactions | Preliminary data indicated high efficacy of an mRNA-based vaccine developed in collaboration between Moderna and the NIAID. The vaccine has now been evaluated in an ongoing phase 3 randomized, controlled trial. New research findings are summarized in a short video. https://nej.md/3tstdX9 | The New England Journal of Medicine | Facebook

Dr Maria Van Kerkhove, WHO's technical lead on COVID-19, talks about the status of the scientific work needed to find the origins of the SARS-CoV-2 virus. 👉Why it is important to understand the origins of pandemics, 👉What is WHO's role in achieving this and, 👉How WHO works to prevent future pandemics. | World Health Organization (WHO)

SARS-Co-V2 is a novel coronavirus, causing the disease COVID-19. On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, infectious disease expert and head of Mayo Clinic’s Vaccine Research Group, explains the science behind how the virus makes people sick, and what the virus does to the body. Dr. Poland will also discuss the latest information on clinical trials and vaccine research to fight the disease outbreak. | Mayo Clinic

‘Supercharged’ cells are helping scientists at UNSW Medicine & Health's Kirby Institute analyse SARS-CoV-2 variants faster than anywhere else in the world. This will help to identify new variants, test their ability to evade vaccines, and inform the public health response in real time. #COVID19 Read more: unsw.to/supercharged-cells | UNSW

6.8M views · 6.6K reactions | What are the SARS-CoV-2 variants circulating at this time? How are variants classified as variants of interest or concern? What does this mean for the public? WHO’s COVID-19 Technical Lead Dr Maria Van Kerkhove explains in this Science in 5 video. | World Health Organization Western Pacific Region | Facebook